Panitumumab: all 196 studies that test it
Page 1 of 2. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell CarcinomaRecruitingNCT07741643Phase 1
- A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRIRecruitingNCT07543744Phase 1
- Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical ProceduresRecruitingNCT07493447Early Phase 1
- ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal CancerRecruitingNCT07318389Early Phase 1
- A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C MutationRecruitingNCT07172919Phase 2
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsRecruitingNCT06998940Phase 3
- A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal CancerRecruitingNCT06820463Phase 2
- Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck CancerRecruitingNCT06819228Phase 1
- Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal CancerRecruitingNCT06509126Phase 3
- The Sagittarius TrialRecruitingNCT06490536Phase 3
- Dynamic Changes in Circulating Tumour Cells Protein ExpressionRecruitingNCT06314997Phase 2
- Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C MutationRecruitingNCT06252649Phase 3
- Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal CancerRecruitingNCT06245356Phase 2
- Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck CancerRecruitingNCT05945875Phase 1
- Evaluating 111In Panitumumab for Nodal Staging in Head and Neck CancerRecruitingNCT05901545Phase 1
- Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)RecruitingNCT05845450Phase 2
- (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell CarcinomaRecruitingNCT05747625Phase 1
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruitingNCT05564377Phase 2
- Phase II Panitumumab-IRDye800 in Head & Neck CancerRecruitingNCT04511078Phase 2
- Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical ProceduresRecruitingNCT04085887Phase 1/2
- Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During SurgeryRecruitingNCT03582124Phase 1/2
- Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing SurgeryRecruitingNCT03510208Phase 1/2
- Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing SurgeryRecruitingNCT03384238Phase 1/2
- The Drug Rediscovery Protocol (DRUP Trial)RecruitingNCT02925234Phase 2
- Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C MutationCompletedNCT05198934Phase 3Results posted
- Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the SkinTerminatedNCT04163952Phase 1Results posted
- Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerActive, not recruitingNCT04117945Phase 2Results posted
- Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal CancerActive, not recruitingNCT03992456Phase 2Results posted
- Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal CancerActive, not recruitingNCT03983993Phase 2Results posted
- Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck CancerCompletedNCT03733210Phase 1Results posted
- PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRCCompletedNCT03442569Phase 2Results posted
- Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal CancerCompletedNCT03263429Phase 1/2Results posted
- A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal CancerCompletedNCT02613221Phase 1/2Results posted
- Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCCompletedNCT02593175Phase 2Results posted
- FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal CancerTerminatedNCT02508077Phase 2Results posted
- Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal CancerTerminatedNCT02448810Phase 2Results posted
- Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRCCompletedNCT02394795Phase 3Results posted
- Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal CarcinomaCompletedNCT02337946Phase 2Results posted
- Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS TumorsCompletedNCT01927341Phase 1/2Results posted
- Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerTerminatedNCT01916109Phase 2Results posted
- Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With BevacizumabCompletedNCT01814501Phase 2Results posted
- BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)CompletedNCT01750918Phase 1/2Results posted
- Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the AnusCompletedNCT01581840Phase 1/2Results posted
- Panitumumab and Bortezomib for Patients With Advanced Colorectal CancerTerminatedNCT01504477Phase 1/2Results posted
- Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal CancerCompletedNCT01412957Phase 3Results posted
- Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal CancerCompletedNCT01312857Phase 2Results posted
- Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder CancerCompletedNCT01308840Phase 2Results posted
- Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction CancerTerminatedNCT01307956Phase 2Results posted
- Panitumumab and Gemcitabine in Relapsed Ovarian CancerTerminatedNCT01296035Phase 2Results posted
- FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases OnlyCompletedNCT01226719Phase 2Results posted
- CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of VaterCompletedNCT01202409Phase 2Results posted
- Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal AdenocarcinomaTerminatedNCT01182610Phase 2Results posted
- Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal CancerTerminatedNCT01128387Phase 1/2Results posted
- First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type RasTerminatedNCT01057017Phase 2Results posted
- Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLCCompletedNCT01042288Phase 2Results posted
- Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerCompletedNCT01036087Phase 2Results posted
- Panitumumab and Irinotecan for Malignant GliomasTerminatedNCT01017653Phase 2Results posted
- Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast CancerTerminatedNCT01009983Phase 2Results posted
- ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerCompletedNCT01001377Phase 3Results posted
- Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung CancerCompletedNCT00979212Phase 2Results posted
- Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract AdenocarcinomaCompletedNCT00948935Phase 2Results posted
- Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast CancerCompletedNCT00894504Phase 2Results posted
- Study to Evaluate Mechanisms of Acquired Resistance to PanitumumabCompletedNCT00891930Phase 2Results posted
- New Individualized Therapy Trial for Metastatic Colorectal CancerCompletedNCT00867334Phase 1/2Results posted
- Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal CancerCompletedNCT00842257Phase 2Results posted
- Phase II Study of Irinotecan and PanitumumabCompletedNCT00836277Phase 2Results posted
- Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck CancerCompletedNCT00820248Phase 3Results posted
- PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) TumorsCompletedNCT00819780Phase 2Results posted
- Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck CancerCompletedNCT00798655Phase 2Results posted
- Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)CompletedNCT00788957Phase 1/2Results posted
- Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal JunctionCompletedNCT00757172Phase 2Results posted
- A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00756444Phase 2Results posted
- Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal AdenocarcinomaTerminatedNCT00667420Phase 1/2Results posted
- Panitumumab in Children With Solid TumorsCompletedNCT00658658Phase 1Results posted
- Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00655499Phase 2Results posted
- Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyCompletedNCT00630786Phase 1/2Results posted
- Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary EndpointTerminatedNCT00613730Phase 2Results posted
- Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by SurgeryCompletedNCT00601627Phase 2Results posted
- Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal CancerCompletedNCT00578071Phase 1/2Results posted
- Effect of Panitumumab on the Pharmacokinetics of IrinotecanCompletedNCT00563316Phase 1Results posted
- Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00550836Phase 2Results posted
- Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00547157Phase 2Results posted
- Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal CancerCompletedNCT00508404Phase 2Results posted
- Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck CancerCompletedNCT00500760Phase 2Results posted
- PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of ResponseCompletedNCT00454779Phase 2Results posted
- PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)CompletedNCT00446446Phase 2Results posted
- SPIRITT - Second-Line Panitumumab Irinotecan Treatment TrialCompletedNCT00418938Phase 2Results posted
- Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to TreatmentCompletedNCT00411450Phase 2Results posted
- PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine EfficacyCompletedNCT00364013Phase 3Results posted
- Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy AloneCompletedNCT00339183Phase 3Results posted
- PACCE: Panitumumab Advanced Colorectal Cancer Evaluation StudyCompletedNCT00115765Phase 3Results posted
- Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal CancerCompletedNCT00113763Phase 3Results posted
- Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal CancerCompletedNCT00111761Phase 2Results posted
- Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00094835Phase 1/2Results posted
- Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal CancerCompletedNCT00089635Phase 2Results posted
- Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin ChemotherapyCompletedNCT00083616Phase 2Results posted
- Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer PatientsTerminatedNCT06332079Phase 2
- A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal CancersTerminatedNCT06194877Phase 1
- A Phase 2 Basket Trial in Which Patients With Advanced Solid Tumors Carrying the KRAS G12C mUtation Receive Treatment With a Combination of Sotorasib and PanitumumabActive, not recruitingNCT05993455Phase 2
- Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)Active, not recruitingNCT05638295Phase 2